The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preclinical Imaging-Global Market Insights and Sales Trends 2024
Synopsis
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
The global Preclinical Imaging market size is expected to reach US$ 3021.2 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical Imaging in various end use industries. The expanding demands from the Hospitals, Diagnostics Centers and Others,, are propelling Preclinical Imaging market. Optical Imaging Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nuclear Imaging Systems segment is estimated at % CAGR for the next seven-year period.
In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical Imaging covered in this report include Perkinelmer, Bruker, Fujifilm, Mediso, Milabs, MR Solutions, Aspect Imaging, Li-Cor Biosciences and Trifoil Imaging, etc.
The global Preclinical Imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perkinelmer
Bruker
Fujifilm
Mediso
Milabs
MR Solutions
Aspect Imaging
Li-Cor Biosciences
Trifoil Imaging
Miltenyi Biotec
Global Preclinical Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical Imaging market, Segment by Type:
Optical Imaging Systems
Nuclear Imaging Systems
Micro-MRI Systems
Micro-Ultrasound Systems
Micro-CT Systems
Preclinical Photoacoustic Imaging Systems
Preclinical Magnetic Particle Imaging (MPI) Systems
Global Preclinical Imaging market, by Application
Hospitals
Diagnostics Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Preclinical Imaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Preclinical Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
The global Preclinical Imaging market size is expected to reach US$ 3021.2 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical Imaging in various end use industries. The expanding demands from the Hospitals, Diagnostics Centers and Others,, are propelling Preclinical Imaging market. Optical Imaging Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nuclear Imaging Systems segment is estimated at % CAGR for the next seven-year period.
In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical Imaging covered in this report include Perkinelmer, Bruker, Fujifilm, Mediso, Milabs, MR Solutions, Aspect Imaging, Li-Cor Biosciences and Trifoil Imaging, etc.
The global Preclinical Imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Perkinelmer
Bruker
Fujifilm
Mediso
Milabs
MR Solutions
Aspect Imaging
Li-Cor Biosciences
Trifoil Imaging
Miltenyi Biotec
Global Preclinical Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical Imaging market, Segment by Type:
Optical Imaging Systems
Nuclear Imaging Systems
Micro-MRI Systems
Micro-Ultrasound Systems
Micro-CT Systems
Preclinical Photoacoustic Imaging Systems
Preclinical Magnetic Particle Imaging (MPI) Systems
Global Preclinical Imaging market, by Application
Hospitals
Diagnostics Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Preclinical Imaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Preclinical Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Preclinical Imaging Market Overview
1.1 Preclinical Imaging Product Overview
1.2 Preclinical Imaging Market Segment by Type
1.2.1 Optical Imaging Systems
1.2.2 Nuclear Imaging Systems
1.2.3 Micro-MRI Systems
1.2.4 Micro-Ultrasound Systems
1.2.5 Micro-CT Systems
1.2.6 Preclinical Photoacoustic Imaging Systems
1.2.7 Preclinical Magnetic Particle Imaging (MPI) Systems
1.3 Global Preclinical Imaging Market Size by Type
1.3.1 Global Preclinical Imaging Market Size Overview by Type (2018-2029)
1.3.2 Global Preclinical Imaging Historic Market Size Review by Type (2018-2023)
1.3.3 Global Preclinical Imaging Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Preclinical Imaging Sales Breakdown by Type (2018-2023)
1.4.2 Europe Preclinical Imaging Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Preclinical Imaging Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Preclinical Imaging Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Preclinical Imaging Sales Breakdown by Type (2018-2023)
2 Global Preclinical Imaging Market Competition by Company
2.1 Global Top Players by Preclinical Imaging Sales (2018-2023)
2.2 Global Top Players by Preclinical Imaging Revenue (2018-2023)
2.3 Global Top Players by Preclinical Imaging Price (2018-2023)
2.4 Global Top Manufacturers Preclinical Imaging Manufacturing Base Distribution, Sales Area, Product Type
2.5 Preclinical Imaging Market Competitive Situation and Trends
2.5.1 Preclinical Imaging Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Preclinical Imaging Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preclinical Imaging as of 2022)
2.7 Date of Key Manufacturers Enter into Preclinical Imaging Market
2.8 Key Manufacturers Preclinical Imaging Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Preclinical Imaging Status and Outlook by Region
3.1 Global Preclinical Imaging Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Preclinical Imaging Historic Market Size by Region
3.2.1 Global Preclinical Imaging Sales in Volume by Region (2018-2023)
3.2.2 Global Preclinical Imaging Sales in Value by Region (2018-2023)
3.2.3 Global Preclinical Imaging Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Preclinical Imaging Forecasted Market Size by Region
3.3.1 Global Preclinical Imaging Sales in Volume by Region (2024-2029)
3.3.2 Global Preclinical Imaging Sales in Value by Region (2024-2029)
3.3.3 Global Preclinical Imaging Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Preclinical Imaging by Application
4.1 Preclinical Imaging Market Segment by Application
4.1.1 Hospitals
4.1.2 Diagnostics Centers
4.1.3 Others
4.2 Global Preclinical Imaging Market Size by Application
4.2.1 Global Preclinical Imaging Market Size Overview by Application (2018-2029)
4.2.2 Global Preclinical Imaging Historic Market Size Review by Application (2018-2023)
4.2.3 Global Preclinical Imaging Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Preclinical Imaging Sales Breakdown by Application (2018-2023)
4.3.2 Europe Preclinical Imaging Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Preclinical Imaging Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Preclinical Imaging Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Preclinical Imaging Sales Breakdown by Application (2018-2023)
5 North America Preclinical Imaging by Country
5.1 North America Preclinical Imaging Historic Market Size by Country
5.1.1 North America Preclinical Imaging Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Preclinical Imaging Sales in Volume by Country (2018-2023)
5.1.3 North America Preclinical Imaging Sales in Value by Country (2018-2023)
5.2 North America Preclinical Imaging Forecasted Market Size by Country
5.2.1 North America Preclinical Imaging Sales in Volume by Country (2024-2029)
5.2.2 North America Preclinical Imaging Sales in Value by Country (2024-2029)
6 Europe Preclinical Imaging by Country
6.1 Europe Preclinical Imaging Historic Market Size by Country
6.1.1 Europe Preclinical Imaging Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Preclinical Imaging Sales in Volume by Country (2018-2023)
6.1.3 Europe Preclinical Imaging Sales in Value by Country (2018-2023)
6.2 Europe Preclinical Imaging Forecasted Market Size by Country
6.2.1 Europe Preclinical Imaging Sales in Volume by Country (2024-2029)
6.2.2 Europe Preclinical Imaging Sales in Value by Country (2024-2029)
7 Asia-Pacific Preclinical Imaging by Region
7.1 Asia-Pacific Preclinical Imaging Historic Market Size by Region
7.1.1 Asia-Pacific Preclinical Imaging Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Preclinical Imaging Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Preclinical Imaging Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Preclinical Imaging Forecasted Market Size by Region
7.2.1 Asia-Pacific Preclinical Imaging Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Preclinical Imaging Sales in Value by Region (2024-2029)
8 Latin America Preclinical Imaging by Country
8.1 Latin America Preclinical Imaging Historic Market Size by Country
8.1.1 Latin America Preclinical Imaging Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Preclinical Imaging Sales in Volume by Country (2018-2023)
8.1.3 Latin America Preclinical Imaging Sales in Value by Country (2018-2023)
8.2 Latin America Preclinical Imaging Forecasted Market Size by Country
8.2.1 Latin America Preclinical Imaging Sales in Volume by Country (2024-2029)
8.2.2 Latin America Preclinical Imaging Sales in Value by Country (2024-2029)
9 Middle East and Africa Preclinical Imaging by Country
9.1 Middle East and Africa Preclinical Imaging Historic Market Size by Country
9.1.1 Middle East and Africa Preclinical Imaging Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Preclinical Imaging Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Preclinical Imaging Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Preclinical Imaging Forecasted Market Size by Country
9.2.1 Middle East and Africa Preclinical Imaging Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Preclinical Imaging Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Perkinelmer
10.1.1 Perkinelmer Company Information
10.1.2 Perkinelmer Introduction and Business Overview
10.1.3 Perkinelmer Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Perkinelmer Preclinical Imaging Products Offered
10.1.5 Perkinelmer Recent Development
10.2 Bruker
10.2.1 Bruker Company Information
10.2.2 Bruker Introduction and Business Overview
10.2.3 Bruker Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bruker Preclinical Imaging Products Offered
10.2.5 Bruker Recent Development
10.3 Fujifilm
10.3.1 Fujifilm Company Information
10.3.2 Fujifilm Introduction and Business Overview
10.3.3 Fujifilm Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fujifilm Preclinical Imaging Products Offered
10.3.5 Fujifilm Recent Development
10.4 Mediso
10.4.1 Mediso Company Information
10.4.2 Mediso Introduction and Business Overview
10.4.3 Mediso Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mediso Preclinical Imaging Products Offered
10.4.5 Mediso Recent Development
10.5 Milabs
10.5.1 Milabs Company Information
10.5.2 Milabs Introduction and Business Overview
10.5.3 Milabs Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Milabs Preclinical Imaging Products Offered
10.5.5 Milabs Recent Development
10.6 MR Solutions
10.6.1 MR Solutions Company Information
10.6.2 MR Solutions Introduction and Business Overview
10.6.3 MR Solutions Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.6.4 MR Solutions Preclinical Imaging Products Offered
10.6.5 MR Solutions Recent Development
10.7 Aspect Imaging
10.7.1 Aspect Imaging Company Information
10.7.2 Aspect Imaging Introduction and Business Overview
10.7.3 Aspect Imaging Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aspect Imaging Preclinical Imaging Products Offered
10.7.5 Aspect Imaging Recent Development
10.8 Li-Cor Biosciences
10.8.1 Li-Cor Biosciences Company Information
10.8.2 Li-Cor Biosciences Introduction and Business Overview
10.8.3 Li-Cor Biosciences Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Li-Cor Biosciences Preclinical Imaging Products Offered
10.8.5 Li-Cor Biosciences Recent Development
10.9 Trifoil Imaging
10.9.1 Trifoil Imaging Company Information
10.9.2 Trifoil Imaging Introduction and Business Overview
10.9.3 Trifoil Imaging Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Trifoil Imaging Preclinical Imaging Products Offered
10.9.5 Trifoil Imaging Recent Development
10.10 Miltenyi Biotec
10.10.1 Miltenyi Biotec Company Information
10.10.2 Miltenyi Biotec Introduction and Business Overview
10.10.3 Miltenyi Biotec Preclinical Imaging Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Miltenyi Biotec Preclinical Imaging Products Offered
10.10.5 Miltenyi Biotec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Preclinical Imaging Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Preclinical Imaging Industrial Chain Analysis
11.4 Preclinical Imaging Market Dynamics
11.4.1 Preclinical Imaging Industry Trends
11.4.2 Preclinical Imaging Market Drivers
11.4.3 Preclinical Imaging Market Challenges
11.4.4 Preclinical Imaging Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Preclinical Imaging Distributors
12.3 Preclinical Imaging Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
